These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1863470)

  • 1. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
    Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P; Gairin JE; Bénichou S; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
    Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
    J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A; Gluckman JC; Montagnier L; Bahraoui E
    J Virol; 1993 Mar; 67(3):1693-7. PubMed ID: 7679751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
    McLain L; Porta C; Lomonossoff GP; Durrani Z; Dimmock NJ
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):327-34. PubMed ID: 7786579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
    Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
    J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
    Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
    Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
    Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
    FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
    Li H; Liu ZQ; Ding J; Chen YH
    Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling.
    Stigler RD; Rüker F; Katinger D; Elliott G; Höhne W; Henklein P; Ho JX; Keeling K; Carter DC; Nugel E
    Protein Eng; 1995 May; 8(5):471-9. PubMed ID: 8532669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
    Kang CY
    Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.
    Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K
    J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
    Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
    J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HIV-2 Gag and Env antigens in E. coli.
    Ulrich R; Siakkou H; Krüger DH
    Acta Virol; 1992 Oct; 36(5):491. PubMed ID: 1364028
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
    McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ
    Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Gorny MK; Lake D; Xu JY; Matsumoto Y; Sugano T; Masuho Y; Mitchell WM; Hersh E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3185-9. PubMed ID: 2326277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.